Literature DB >> 12197312

Guiding molecules towards drug-likeness.

William J Egan1, W Patrick Walters, Mark A Murcko.   

Abstract

This review discusses computational methods for the prediction of drug-likeness. The coverage of published works include the assessment of historical practices of lead generation and optimization, surveys of the properties of known drugs and their constituent fragments and scaffolds, methods for delineating drug space, optimization techniques for simultaneously enhancing multiple properties and drug-like characteristics, similarity metrics and the application of more advanced pattern recognition algorithms for the prediction of drug-likeness. Areas which could be improved in this field are the scope of the datasets used to build models, the chemical interpretability of models, the use of multivariate optimization methods for drug design and the application of underappreciated statistical methods proven to work in other fields.

Mesh:

Substances:

Year:  2002        PMID: 12197312

Source DB:  PubMed          Journal:  Curr Opin Drug Discov Devel        ISSN: 1367-6733


  11 in total

1.  In silico QSAR analysis of quercetin reveals its potential as therapeutic drug for Alzheimer's disease.

Authors:  Md Rezaul Islam; Aubhishek Zaman; Iffat Jahan; Rajib Chakravorty; Sajib Chakraborty
Journal:  J Young Pharm       Date:  2013-12-15

2.  Structure based design of selective SHP2 inhibitors by De novo design, synthesis and biological evaluation.

Authors:  Wen-Shan Liu; Wen-Yan Jin; Liang Zhou; Xing-Hua Lu; Wei-Ya Li; Ying Ma; Run-Ling Wang
Journal:  J Comput Aided Mol Des       Date:  2019-07-12       Impact factor: 3.686

3.  Combinatorial library-based design with Basis Products.

Authors:  Joe Zhongxiang Zhou; Shenghua Shi; Jim Na; Zhengwei Peng; Tom Thacher
Journal:  J Comput Aided Mol Des       Date:  2009-07-11       Impact factor: 3.686

4.  Pharmacological Mechanisms Underlying the Hepatoprotective Effects of Ecliptae herba on Hepatocellular Carcinoma.

Authors:  Botao Pan; Wenxiu Pan; Zheng Lu; Chenglai Xia
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-16       Impact factor: 2.629

5.  A physicochemical descriptor-based scoring scheme for effective and rapid filtering of kinase-like chemical space.

Authors:  Narender Singh; Hongmao Sun; Sidhartha Chaudhury; Mohamed Diwan M Abdulhameed; Anders Wallqvist; Gregory Tawa
Journal:  J Cheminform       Date:  2012-02-08       Impact factor: 5.514

6.  Synthesis, bioactivity, 3D-QSAR studies of novel dibenzofuran derivatives as PTP-MEG2 inhibitors.

Authors:  Ying Ma; Hui-Yu Wei; Yu-Ze Zhang; Wen-Yan Jin; Hong-Lian Li; Hui Zhou; Xian-Chao Cheng; Run-Ling Wang
Journal:  Oncotarget       Date:  2017-06-13

7.  Three dimensional model of severe acute respiratory syndrome coronavirus helicase ATPase catalytic domain and molecular design of severe acute respiratory syndrome coronavirus helicase inhibitors.

Authors:  Marcin Hoffmann; Krystian Eitner; Marcin von Grotthuss; Leszek Rychlewski; Ewa Banachowicz; Tomasz Grabarkiewicz; Tomasz Szkoda; Andrzej Kolinski
Journal:  J Comput Aided Mol Des       Date:  2006-09-14       Impact factor: 3.686

8.  Lead Optimization in Discovery Drug Metabolism and Pharmacokinetics/Case study: The Hepatitis C Virus (HCV) Protease Inhibitor SCH 503034.

Authors:  K-C Cheng; Walter A Korfmacher; Ronald E White; F George Njoroge
Journal:  Perspect Medicin Chem       Date:  2007-06-26

9.  An improved relaxed complex scheme for receptor flexibility in computer-aided drug design.

Authors:  Rommie E Amaro; Riccardo Baron; J Andrew McCammon
Journal:  J Comput Aided Mol Des       Date:  2008-01-15       Impact factor: 3.686

10.  Quantum chemical insight into molecular structure, NBO analysis of the hydrogen-bonded interactions, spectroscopic (FT-IR, FT-Raman), drug likeness and molecular docking of the novel anti COVID-19 molecule 2-[(4,6-diaminopyrimidin-2-yl)sulfanyl]-N-(4-fluorophenyl)acetamide - dimer.

Authors:  S J Jenepha Mary; Mohd Usman Mohd Siddique; Sayantan Pradhan; Venkatesan Jayaprakash; C James
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2020-08-12       Impact factor: 4.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.